These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17471005)

  • 1. [Several PTH assay and the problem].
    Kato H; Mitarai T
    Clin Calcium; 2007 May; 17(5):745-51. PubMed ID: 17471005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
    Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur.
    Amal L; Bergmann P
    Clin Lab; 2004; 50(11-12):695-702. PubMed ID: 15575312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PTH measurement: where do we stand?].
    Marangella M
    G Ital Nefrol; 2009; 26(5):600-7. PubMed ID: 19802805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of a new PTH assay (the comparison between whole-PTH and intact-PTH assay)].
    Ito N; Fukumoto S
    Clin Calcium; 2004 Sep; 14(9):55-6. PubMed ID: 15577110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management.
    Cantor T
    Semin Dial; 2005; 18(5):359-64. PubMed ID: 16191171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone].
    Tanaka M; Fukagawa M
    Clin Calcium; 2006 Jun; 16(6):927-34. PubMed ID: 16751687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PTH assay: new and future].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2001 Aug; 11(8):1019-23. PubMed ID: 15775609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
    Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
    J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a scintillation proximity assay for high-throughput measurement of intact parathyroid hormone.
    Frolik CA; Black EC; Chandrasekhar S; Adrian MD
    Anal Biochem; 1998 Dec; 265(2):216-24. PubMed ID: 9882395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The present conditions and problems for PTH assay].
    Toyama M; Miura M
    Clin Calcium; 2005 Dec; 15(12):45-50. PubMed ID: 16322673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and clinical utility of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone in the horse.
    Estepa JC; Garfia B; Gao PR; Cantor T; Rodriguez M; Aguilera-Tejero E
    Equine Vet J; 2003 May; 35(3):291-5. PubMed ID: 12755433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAP survey of parathyroid hormone assays.
    Klee GG; Shikegawa J; Trainer TD
    Arch Pathol Lab Med; 1986 Jul; 110(7):588-91. PubMed ID: 3755023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transport temperature on the Scantibodies total intact parathyroid hormone immunoradiometric assay using the RIAMAT-280.
    Plancha-Mansanet MC; Félix-Fontestad J; Caballero-Calabuig E; Reyes-Ojeda MD; Abreu-Sánchez P; Sopena-Novales P; Martínez-Sanchís B
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):174-6. PubMed ID: 20144977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical issues of PTH assays in CKD.
    Komaba H; Goto S; Fukagawa M
    Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of parathyroid hormone ex vivo in haemodialysis patients.
    Teal TK; Reed M; Stevens PE; Lamb EJ
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):191-3. PubMed ID: 12662412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.